ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 5176

$901K Total Retail Price of All Prescriptions

Rank: 345 out of 5176

888 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 888 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 16,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,106 967 1 1
LEVOTHYROXINE SODIUM 892 797 2 4
AMLODIPINE BESYLATE 806 750 3 2
OMEPRAZOLE 736 650 4 3
METFORMIN HCL 721 627 5 7
LISINOPRIL 664 585 6 5
GLIMEPIRIDE 586 520 7 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 470 403 8 49
ALENDRONATE SODIUM 453 416 9 18
ZOLPIDEM TARTRATE 419 388 10 17
MELOXICAM 404 372 11 53
METOPROLOL TARTRATE 310 277 12 6
DIOVAN HCT 308 274 13 39
TAMSULOSIN HCL 265 246 14 20
ATENOLOL 245 245 15 12
SINGULAIR 224 201 16 62
NEXIUM 210 161 17 16
CLOTRIMAZOLE-BETAMETHASONE 196 181 18 94
GABAPENTIN 192 184 19 21
CARVEDILOL 191 150 20 24
LOSARTAN POTASSIUM 191 180 20 14
JANUVIA 185 169 22 25
METOPROLOL SUCCINATE 184 178 23 11
DONEPEZIL HCL 181 181 24 28
PREDNISONE 181 158 24 52
PROMETHAZINE HCL 173 148 R 26 221
AMLODIPINE BESYLATE-BENAZEPRIL 170 121 27 55
METFORMIN HCL ER 169 151 28 57
TRIAMTERENE-HCTZ 167 159 29 86
DIOVAN 160 158 30 19
AMOX TR-POTASSIUM CLAVULANATE 159 135 31 141
ATENOLOL-CHLORTHALIDONE 159 137 31 161
NAPROXEN 158 131 33 95
LOVAZA 151 123 34 43
LOSARTAN-HYDROCHLOROTHIAZIDE 150 148 35 35
ACTOS 150 134 35 85
HYDROCHLOROTHIAZIDE 149 131 37 10
WARFARIN SODIUM 149 145 37 13
TRAMADOL HCL-ACETAMINOPHEN 149 148 37 116
MONTELUKAST SODIUM 135 112 40 123
DICLOFENAC SODIUM 134 129 41 160
PLAVIX 129 121 42 29
FUROSEMIDE 124 122 43 8
CILOSTAZOL 117 116 44 206
METHYLPREDNISOLONE 109 86 45 218
AZITHROMYCIN 107 86 46 42
CLOPIDOGREL 107 95 46 26
CRESTOR 100 90 48 15
ADVAIR DISKUS 98 79 49 32
ATORVASTATIN CALCIUM 92 77 50 9
FINASTERIDE 87 87 51 69
IBANDRONATE SODIUM 86 75 52 211
LANTUS 86 58 52 66
ENALAPRIL MALEATE 85 80 54 22
MOMETASONE FUROATE 75 67 55 251
DOXYCYCLINE HYCLATE 75 63 55 247
LOVASTATIN 71 64 57 46
MECLIZINE HCL 68 66 58 81
PROCTOZONE-HC 66 65 59 171
PROAIR HFA 65 52 60 60
COMBIVENT 65 62 60 156
FENOFIBRATE 64 62 62 102
NASONEX 62 55 63 178
VALSARTAN-HYDROCHLOROTHIAZIDE 62 51 63 292
VENTOLIN HFA 62 56 63 64
CIPROFLOXACIN HCL 60 58 66 84
GLIPIZIDE 60 57 66 63
SERTRALINE HCL 57 55 68 30
JANUMET 57 35 68 77
VOLTAREN 55 55 70 97
ORPHENADRINE CITRATE 53 43 R 71 575
FOSINOPRIL SODIUM 53 53 71 105
ISOSORBIDE MONONITRATE ER 52 52 73 44
ACTONEL 52 44 73 134
RAMIPRIL 51 48 75 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.